MRI safety information
NOTE: Patients that received a SPRINT System prior to September 1st, 2022, should contact SPR Therapeutics to obtain specific MRI safety information. (Phone: 844-378-9108)
All other SPRINT patients should use the information listed below:
NOTE: There should be no section of Lead visible above the skin.
NOTE: If a Lead is placed in an individual with an existing retained Lead remnant, the new Lead should not be placed in a location where it could touch the original Lead remnant. During MRI, two MicroLead fragments touching can result in an increase in temperature of the Lead remnants and surrounding tissue where they touch.